论文部分内容阅读
自1984年4月21日至1985年8月20日试服萍芷片治疗鼻窦炎140例。现将连续观察的85例的疗效报告如下: 一、诊断标准、用药规则及疗效评定标准 1.病例选择:以慢性化脓性鼻窦炎为主。以变态反应病变为主者或伴有窦口严重阻塞者基本上不予选用。
Since April 21, 1984 to August 20, 1985 trial serving Pingzhi tablets treatment of sinusitis in 140 cases. Now continuous observation of the efficacy of the report of 85 cases are as follows: First, the diagnostic criteria, medication rules and efficacy evaluation criteria 1. Case Selection: Chronic purulent sinusitis. Mainly to allergic lesions or with severe obstruction of the ostium is basically not to use.